{"transactions":[{"id":686963,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-14T20:48:18.000Z","date":"2026-08-12","kind":"gift","planned":false,"acquired":false,"shares":32220,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an in-kind charitable contribution of 32,220 shares of DNLI to a donor advised fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2120384,"source":{"system":"sec-edgar","filing":"0001724310-26-000007","document":"wk-form4_1786740495.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000172431026000007/wk-form4_1786740495.xml","form_type":"4"}},{"id":943260,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-08T21:20:05.000Z","date":"2026-01-06","kind":"sale","planned":false,"acquired":false,"shares":35198,"price":16.5,"value":580767.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 184,915 Unvested RSUs."}],"balance_after":296833,"source":{"system":"sec-edgar","filing":"0001724310-26-000004","document":"wk-form4_1767907202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000172431026000004/wk-form4_1767907202.xml","form_type":"4"}},{"id":951630,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-05T23:48:48.000Z","date":"2026-01-03","kind":"grant","planned":false,"acquired":true,"shares":236880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option shall vest on January 3, 2027, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date"}],"balance_after":236880,"derivative":{"exercise_price":16.27,"expiration_date":"2036-01-03","underlying":"Common Stock","underlying_shares":236880},"source":{"system":"sec-edgar","filing":"0001724310-26-000001","document":"wk-form4_1767656925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000172431026000001/wk-form4_1767656925.xml","form_type":"4"}},{"id":951629,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-05T23:48:48.000Z","date":"2026-01-03","kind":"grant","planned":false,"acquired":true,"shares":78960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2027 (the \"Vesting\nCommencement Date\") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service\nprovider of the Issuer through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 184,915 Unvested RSUs."}],"balance_after":332031,"source":{"system":"sec-edgar","filing":"0001724310-26-000001","document":"wk-form4_1767656925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000172431026000001/wk-form4_1767656925.xml","form_type":"4"}},{"id":1046831,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-09-05T20:43:51.000Z","date":"2025-09-03","kind":"gift","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an in-kind charitable contribution of 50,000 shares of DNLI to a donor advised fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2152604,"source":{"system":"sec-edgar","filing":"0001724310-25-000005","document":"wk-form4_1757105029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000172431025000005/wk-form4_1757105029.xml","form_type":"4"}},{"id":1088618,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-07-11T21:13:23.000Z","date":"2025-07-09","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the option will vest on March 8, 2018 and an additional 1/48 of the shares vest monthly thereafter."}],"balance_after":20369,"derivative":{"exercise_price":5.28,"expiration_date":"2027-03-07","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001714899-25-000149","document":"wk-form4_1752268398.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489925000149/wk-form4_1752268398.xml","form_type":"4"}},{"id":1088617,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-07-11T21:13:23.000Z","date":"2025-07-09","kind":"exercise","planned":true,"acquired":false,"shares":455282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days."}],"balance_after":622809,"derivative":{"exercise_price":0.68,"expiration_date":"2025-08-21","underlying":"Common Stock","underlying_shares":455282},"source":{"system":"sec-edgar","filing":"0001714899-25-000149","document":"wk-form4_1752268398.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489925000149/wk-form4_1752268398.xml","form_type":"4"}},{"id":1088616,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-11T21:13:23.000Z","date":"2025-07-09","kind":"sale","planned":true,"acquired":false,"shares":495282,"price":15,"value":7429230.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported by the Reporting Person were made pursuant to a previously signed/adopted 10b5-1 Selling plan dated 09/16/2024. The shares sold primarily relate to 455,282 stock options that expire on 08/21/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $15.00 to $15.08 per share. Upon request by the Commission staff, the Issuer, or a\nsecurity holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 177,940 Unvested RSUs."}],"balance_after":253071,"source":{"system":"sec-edgar","filing":"0001714899-25-000149","document":"wk-form4_1752268398.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489925000149/wk-form4_1752268398.xml","form_type":"4"}},{"id":1088615,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-11T21:13:23.000Z","date":"2025-07-09","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":5.28,"value":211200.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 177,940 Unvested RSUs."}],"balance_after":748353,"source":{"system":"sec-edgar","filing":"0001714899-25-000149","document":"wk-form4_1752268398.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489925000149/wk-form4_1752268398.xml","form_type":"4"}},{"id":1088614,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-11T21:13:23.000Z","date":"2025-07-09","kind":"exercise","planned":true,"acquired":true,"shares":455282,"price":0.68,"value":309591.76,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 177,940 Unvested RSUs."}],"balance_after":708353,"source":{"system":"sec-edgar","filing":"0001714899-25-000149","document":"wk-form4_1752268398.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489925000149/wk-form4_1752268398.xml","form_type":"4"}},{"id":1306729,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-09T01:24:43.000Z","date":"2025-01-07","kind":"sale","planned":false,"acquired":false,"shares":7650,"price":20.81,"value":159196.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 177,940 Unvested RSUs."}],"balance_after":253071,"source":{"system":"sec-edgar","filing":"0001714899-25-000049","document":"wk-form4_1736385877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489925000049/wk-form4_1736385877.xml","form_type":"4"}},{"id":1306728,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-09T01:24:43.000Z","date":"2025-01-06","kind":"sale","planned":false,"acquired":false,"shares":29266,"price":20.22,"value":591758.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.91 to $20.23 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 177,940 Unvested RSUs."}],"balance_after":260721,"source":{"system":"sec-edgar","filing":"0001714899-25-000049","document":"wk-form4_1736385877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489925000049/wk-form4_1736385877.xml","form_type":"4"}},{"id":1308126,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T23:59:45.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":162540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option shall vest on January 3, 2026, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date."}],"balance_after":162540,"derivative":{"exercise_price":21.26,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":162540},"source":{"system":"sec-edgar","filing":"0001714899-25-000028","document":"wk-form4_1736294379.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489925000028/wk-form4_1736294379.xml","form_type":"4"}},{"id":1308125,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-07T23:59:45.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":54180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2026 (the \"Vesting\nCommencement Date\") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service\nprovider of the Issuer through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 192,940 Unvested RSUs."}],"balance_after":289987,"source":{"system":"sec-edgar","filing":"0001714899-25-000028","document":"wk-form4_1736294379.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489925000028/wk-form4_1736294379.xml","form_type":"4"}},{"id":1382981,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-22T20:30:57.000Z","date":"2024-10-18","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days."}],"balance_after":1078091,"derivative":{"exercise_price":0.68,"expiration_date":"2025-08-20","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001714899-24-000206","document":"wk-form4_1729629050.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489924000206/wk-form4_1729629050.xml","form_type":"4"}},{"id":1382980,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-22T20:30:57.000Z","date":"2024-10-18","kind":"sale","planned":true,"acquired":false,"shares":40000,"price":27.69,"value":1107600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $27.49 to $28.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 197,200 Unvested RSUs."}],"balance_after":235807,"source":{"system":"sec-edgar","filing":"0001714899-24-000206","document":"wk-form4_1729629050.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489924000206/wk-form4_1729629050.xml","form_type":"4"}},{"id":1382979,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-22T20:30:57.000Z","date":"2024-10-18","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":0.68,"value":27200.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 197,200 Unvested RSUs."}],"balance_after":275807,"source":{"system":"sec-edgar","filing":"0001714899-24-000206","document":"wk-form4_1729629050.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489924000206/wk-form4_1729629050.xml","form_type":"4"}},{"id":1425362,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-08-22T20:16:23.000Z","date":"2024-08-20","kind":"sale","planned":false,"acquired":false,"shares":2260,"price":23.79,"value":53765.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 197,200 Unvested RSUs."}],"balance_after":235807,"source":{"system":"sec-edgar","filing":"0001714899-24-000197","document":"wk-form4_1724357777.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489924000197/wk-form4_1724357777.xml","form_type":"4"}},{"id":1557597,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-03-29T21:59:11.000Z","date":"2024-03-29","kind":"gift","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an in-kind charitable contribution of 40,000 shares of DNLI to a donor advised fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2202604,"source":{"system":"sec-edgar","filing":"0001714899-24-000097","document":"wk-form4_1711749539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489924000097/wk-form4_1711749539.xml","form_type":"4"}},{"id":1641018,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-16T02:15:20.000Z","date":"2024-02-13","kind":"sale","planned":false,"acquired":false,"shares":9589,"price":17.29,"value":165793.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $17.08 to $17.30 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 202,200 RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reflects 25,759 shares previously disclosed as held indirectly; but have been determined to be held directly."}],"balance_after":238067,"source":{"system":"sec-edgar","filing":"0001714899-24-000061","document":"wk-form4_1708049710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489924000061/wk-form4_1708049710.xml","form_type":"4"}},{"id":1680767,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-11T22:28:16.000Z","date":"2024-01-09","kind":"sale","planned":false,"acquired":false,"shares":7818,"price":19.78,"value":154640.04,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.60 to $20.02 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2268363,"source":{"system":"sec-edgar","filing":"0001714899-24-000039","document":"wk-form4_1705012085.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489924000039/wk-form4_1705012085.xml","form_type":"4"}},{"id":1682766,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-10T00:33:21.000Z","date":"2024-01-05","kind":"sale","planned":false,"acquired":false,"shares":17483,"price":19.43,"value":339694.69,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.36 to $19.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 51,060\nrestricted stock units held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2276181,"source":{"system":"sec-edgar","filing":"0001714899-24-000035","document":"wk-form4_1704846791.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489924000035/wk-form4_1704846791.xml","form_type":"4"}},{"id":1685563,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-05T22:56:27.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":268560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option shall vest on January 3, 2025, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date."}],"balance_after":268560,"derivative":{"exercise_price":20.33,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":268560},"source":{"system":"sec-edgar","filing":"0001714899-24-000008","document":"wk-form4_1704495377.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489924000008/wk-form4_1704495377.xml","form_type":"4"}},{"id":1685562,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-05T22:56:27.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":89520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2025 (the \"Vesting Commencement Date\") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 221,897 RSU's as of January 4, 2024."}],"balance_after":272957,"source":{"system":"sec-edgar","filing":"0001714899-24-000008","document":"wk-form4_1704495377.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489924000008/wk-form4_1704495377.xml","form_type":"4"}},{"id":1798725,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-23T20:32:21.000Z","date":"2023-08-21","kind":"sale","planned":false,"acquired":false,"shares":2309,"price":22.59,"value":52160.31,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":". The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $22.50 to $23.00 per share. Upon request by the Commission staff, the Issuer, or a\nsecurityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 5,000 restricted stock units held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2242604,"source":{"system":"sec-edgar","filing":"0001714899-23-000133","document":"wk-form4_1692822729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000133/wk-form4_1692822729.xml","form_type":"4"}},{"id":1808634,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-08-14T21:13:27.000Z","date":"2023-08-10","kind":"exercise","planned":false,"acquired":false,"shares":2526,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the\noption will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days."}],"balance_after":1118091,"derivative":{"exercise_price":0.68,"expiration_date":"2025-08-20","underlying":"Common Stock","underlying_shares":2526},"source":{"system":"sec-edgar","filing":"0001714899-23-000123","document":"wk-form4_1692047595.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000123/wk-form4_1692047595.xml","form_type":"4"}},{"id":1808633,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-14T21:13:27.000Z","date":"2023-08-10","kind":"sale","planned":false,"acquired":false,"shares":2526,"price":25.03,"value":63225.78,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted August 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $25.00 to $25.11 per share. Upon request by the Commission staff, the Issuer, or a security\nholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2239913,"source":{"system":"sec-edgar","filing":"0001714899-23-000123","document":"wk-form4_1692047595.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000123/wk-form4_1692047595.xml","form_type":"4"}},{"id":1808632,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-14T21:13:27.000Z","date":"2023-08-10","kind":"exercise","planned":false,"acquired":true,"shares":2526,"price":0.68,"value":1717.68,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Exercised shares were issued to the Watts Family 2015 Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2242439,"source":{"system":"sec-edgar","filing":"0001714899-23-000123","document":"wk-form4_1692047595.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000123/wk-form4_1692047595.xml","form_type":"4"}},{"id":1849628,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-06-20T22:28:02.000Z","date":"2023-06-16","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the\nshares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days."}],"balance_after":1120617,"derivative":{"exercise_price":0.68,"expiration_date":"2025-08-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001714899-23-000105","document":"wk-form4_1687300068.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000105/wk-form4_1687300068.xml","form_type":"4"}},{"id":1849627,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-20T22:28:02.000Z","date":"2023-06-16","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":31.4,"value":1570000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted February 10, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2239913,"source":{"system":"sec-edgar","filing":"0001714899-23-000105","document":"wk-form4_1687300068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000105/wk-form4_1687300068.xml","form_type":"4"}},{"id":1849626,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-20T22:28:02.000Z","date":"2023-06-16","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":0.68,"value":34000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2289913,"source":{"system":"sec-edgar","filing":"0001714899-23-000105","document":"wk-form4_1687300068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000105/wk-form4_1687300068.xml","form_type":"4"}},{"id":1914929,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-24T23:10:38.000Z","date":"2023-04-21","kind":"exercise","planned":false,"acquired":false,"shares":24800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the sharessubject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days."}],"balance_after":1170617,"derivative":{"exercise_price":0.68,"expiration_date":"2025-08-20","underlying":"Common Stock","underlying_shares":24800},"source":{"system":"sec-edgar","filing":"0001714899-23-000066","document":"wf-form4_168237782624985.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000066/wf-form4_168237782624985.xml","form_type":"4"}},{"id":1914928,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-24T23:10:38.000Z","date":"2023-04-20","kind":"exercise","planned":false,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the sharessubject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days."}],"balance_after":1195417,"derivative":{"exercise_price":0.68,"expiration_date":"2025-08-20","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001714899-23-000066","document":"wf-form4_168237782624985.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000066/wf-form4_168237782624985.xml","form_type":"4"}},{"id":1914927,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-24T23:10:38.000Z","date":"2023-04-21","kind":"sale","planned":false,"acquired":false,"shares":24800,"price":25.15,"value":623720.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted February 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $25.00 to $25.36 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2239913,"source":{"system":"sec-edgar","filing":"0001714899-23-000066","document":"wf-form4_168237782624985.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000066/wf-form4_168237782624985.xml","form_type":"4"}},{"id":1914926,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-24T23:10:38.000Z","date":"2023-04-21","kind":"exercise","planned":false,"acquired":true,"shares":24800,"price":0.68,"value":16864.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2264713,"source":{"system":"sec-edgar","filing":"0001714899-23-000066","document":"wf-form4_168237782624985.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000066/wf-form4_168237782624985.xml","form_type":"4"}},{"id":1914925,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-24T23:10:38.000Z","date":"2023-04-20","kind":"sale","planned":false,"acquired":false,"shares":200,"price":25,"value":5000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted February 10, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2239913,"source":{"system":"sec-edgar","filing":"0001714899-23-000066","document":"wf-form4_168237782624985.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000066/wf-form4_168237782624985.xml","form_type":"4"}},{"id":1914924,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-24T23:10:38.000Z","date":"2023-04-20","kind":"exercise","planned":false,"acquired":true,"shares":200,"price":0.68,"value":136.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2240113,"source":{"system":"sec-edgar","filing":"0001714899-23-000066","document":"wf-form4_168237782624985.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000066/wf-form4_168237782624985.xml","form_type":"4"}},{"id":2013661,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-16T00:01:28.000Z","date":"2023-02-13","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days."}],"balance_after":1195617,"derivative":{"exercise_price":0.68,"expiration_date":"2025-08-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001714899-23-000029","document":"wf-form4_167650567156375.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000029/wf-form4_167650567156375.xml","form_type":"4"}},{"id":2013660,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-16T00:01:28.000Z","date":"2023-02-13","kind":"sale","acquired":false,"shares":25000,"price":30.08,"value":752000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.00 to $30.26 per share. Upon request by the Commission staff, the Issuer, or asecurityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2239913,"source":{"system":"sec-edgar","filing":"0001714899-23-000029","document":"wf-form4_167650567156375.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000029/wf-form4_167650567156375.xml","form_type":"4"}},{"id":2013659,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-16T00:01:28.000Z","date":"2023-02-13","kind":"exercise","acquired":true,"shares":25000,"price":0.68,"value":17000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2264913,"source":{"system":"sec-edgar","filing":"0001714899-23-000029","document":"wf-form4_167650567156375.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000029/wf-form4_167650567156375.xml","form_type":"4"}},{"id":2013658,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-16T00:01:28.000Z","date":"2023-02-13","kind":"sale","acquired":false,"shares":8815,"price":30.09,"value":265243.35,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $29.95 to $30.24 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 19,697 restricted stock units held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2239913,"source":{"system":"sec-edgar","filing":"0001714899-23-000029","document":"wf-form4_167650567156375.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000029/wf-form4_167650567156375.xml","form_type":"4"}},{"id":2020029,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-14T00:14:01.000Z","date":"2023-02-10","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The vesting of the shares subject to the option is contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on the date the closing price of Issuer's Common Stock equaled or exceeded $40.00 per share on NASDAQ for 90 consecutive trading days, beginning no earlier than June 10, 2018; and 50% of the shares subject to the option vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days, beginning no earlier than June 10, 2018."}],"balance_after":1220617,"derivative":{"exercise_price":0.68,"expiration_date":"2025-08-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001714899-23-000023","document":"wf-form4_167633361457163.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000023/wf-form4_167633361457163.xml","form_type":"4"}},{"id":2020028,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-14T00:14:01.000Z","date":"2023-02-10","kind":"sale","acquired":false,"shares":25000,"price":29.1,"value":727500.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.75 to $29.57 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2229031,"source":{"system":"sec-edgar","filing":"0001714899-23-000023","document":"wf-form4_167633361457163.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000023/wf-form4_167633361457163.xml","form_type":"4"}},{"id":2020027,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-14T00:14:01.000Z","date":"2023-02-10","kind":"exercise","acquired":true,"shares":25000,"price":0.68,"value":17000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2254031,"source":{"system":"sec-edgar","filing":"0001714899-23-000023","document":"wf-form4_167633361457163.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000023/wf-form4_167633361457163.xml","form_type":"4"}},{"id":2020026,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-14T00:14:01.000Z","date":"2023-02-09","kind":"sale","acquired":false,"shares":3433,"price":30.59,"value":105015.47,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.39 to $30.66 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 8,800 restricted stock units held by the Reporting Person"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2229031,"source":{"system":"sec-edgar","filing":"0001714899-23-000023","document":"wf-form4_167633361457163.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000023/wf-form4_167633361457163.xml","form_type":"4"}},{"id":2058912,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-10T02:41:07.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":4800,"price":28.44,"value":136512.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.17 to $28.70 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 15,000 restricted stock units held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2223664,"source":{"system":"sec-edgar","filing":"0001714899-23-000013","document":"wf-form4_167331845186326.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489923000013/wf-form4_167331845186326.xml","form_type":"4"}},{"id":2062839,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-06T02:07:05.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":246720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to the option shall vest on January 3, 2024, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date."}],"balance_after":246720,"derivative":{"exercise_price":27.63,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":246720},"source":{"system":"sec-edgar","filing":"0001209191-23-002179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919123002179/doc4.xml","form_type":"4"}},{"id":2062838,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-06T02:07:05.000Z","date":"2023-01-04","kind":"sale","acquired":false,"shares":5029,"price":28.73,"value":144483.17,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.58 to $29.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 15,500 RSUs held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2213464,"source":{"system":"sec-edgar","filing":"0001209191-23-002179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919123002179/doc4.xml","form_type":"4"}},{"id":2062837,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-06T02:07:05.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":82240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2024 (the \"Vesting Commencement Date\") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 15,500 RSUs held by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 231,934 RSUs."}],"balance_after":231934,"source":{"system":"sec-edgar","filing":"0001209191-23-002179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919123002179/doc4.xml","form_type":"4"}},{"id":2176144,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-08-23T20:48:29.000Z","date":"2022-08-19","kind":"sale","acquired":false,"shares":2404,"price":33.22,"value":79860.88,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $33.11 to $33.37 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 5,000 restricted stock units held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2202993,"source":{"system":"sec-edgar","filing":"0001714899-22-000129","document":"wf-form4_166128769265555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489922000129/wf-form4_166128769265555.xml","form_type":"4"}},{"id":2394623,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-15T23:58:26.000Z","date":"2022-02-11","kind":"sale","acquired":false,"shares":9491,"price":34.72,"value":329527.52,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $34.50 to $35.17 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 19,697 restricted stock units held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2129648,"source":{"system":"sec-edgar","filing":"0001714899-22-000042","document":"wf-form4_164496949316138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489922000042/wf-form4_164496949316138.xml","form_type":"4"}},{"id":2401843,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-11T22:19:21.000Z","date":"2022-02-10","kind":"exercise","acquired":false,"shares":6118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option were fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":9.6,"expiration_date":"2027-08-21","underlying":"Common Stock","underlying_shares":6118},"source":{"system":"sec-edgar","filing":"0001714899-22-000035","document":"wf-form4_164461792855991.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489922000035/wf-form4_164461792855991.xml","form_type":"4"}},{"id":2401842,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-11T22:19:21.000Z","date":"2022-02-10","kind":"exercise","acquired":false,"shares":64631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option were fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.28,"expiration_date":"2027-03-07","underlying":"Common Stock","underlying_shares":64631},"source":{"system":"sec-edgar","filing":"0001714899-22-000035","document":"wf-form4_164461792855991.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489922000035/wf-form4_164461792855991.xml","form_type":"4"}},{"id":2401841,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-11T22:19:21.000Z","date":"2022-02-10","kind":"exercise","acquired":true,"shares":6118,"price":9.6,"value":58732.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 8800 restricted stock units held by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 189,891 restricted stock units."}],"balance_after":260640,"source":{"system":"sec-edgar","filing":"0001714899-22-000035","document":"wf-form4_164461792855991.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489922000035/wf-form4_164461792855991.xml","form_type":"4"}},{"id":2401840,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-11T22:19:21.000Z","date":"2022-02-10","kind":"exercise","acquired":true,"shares":64631,"price":5.28,"value":341251.68,"ownership":{"direct":true},"balance_after":254522,"source":{"system":"sec-edgar","filing":"0001714899-22-000035","document":"wf-form4_164461792855991.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489922000035/wf-form4_164461792855991.xml","form_type":"4"}},{"id":2401839,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-11T22:19:21.000Z","date":"2022-02-09","kind":"sale","acquired":false,"shares":2719,"price":37.5519,"value":102103.6161,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $37.51 to $37.745 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 8800 restricted stock units held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2119442,"source":{"system":"sec-edgar","filing":"0001714899-22-000035","document":"wf-form4_164461792855991.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489922000035/wf-form4_164461792855991.xml","form_type":"4"}},{"id":2440149,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-07T23:06:21.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":5007,"price":44.78,"value":224213.46,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.44 to $45.05 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 15000 restricted stock units held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2113361,"source":{"system":"sec-edgar","filing":"0001714899-22-000008","document":"wf-form4_164159676820157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489922000008/wf-form4_164159676820157.xml","form_type":"4"}},{"id":2444118,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T00:03:31.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":186500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option shall vest on January 3, 2023, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date."}],"balance_after":186500,"derivative":{"exercise_price":47.27,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":186500},"source":{"system":"sec-edgar","filing":"0001714899-22-000002","document":"wf-form4_164142738905570.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489922000002/wf-form4_164142738905570.xml","form_type":"4"}},{"id":2444117,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-06T00:03:31.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2023 (the \"Vesting Commencement Date\") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 213,691 restricted stock units."}],"balance_after":213691,"source":{"system":"sec-edgar","filing":"0001714899-22-000002","document":"wf-form4_164142738905570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489922000002/wf-form4_164142738905570.xml","form_type":"4"}},{"id":2486030,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-03T21:23:35.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":805,"price":46.35,"value":37311.75,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $45.99 to $46.71 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2103368,"source":{"system":"sec-edgar","filing":"0001714899-21-000114","document":"wf-form4_163856660331306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489921000114/wf-form4_163856660331306.xml","form_type":"4"}},{"id":2486029,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-03T21:23:35.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":9012,"price":45.3,"value":408243.6,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $44.96 to $45.89 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2104173,"source":{"system":"sec-edgar","filing":"0001714899-21-000114","document":"wf-form4_163856660331306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489921000114/wf-form4_163856660331306.xml","form_type":"4"}},{"id":2486028,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-03T21:23:35.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":8516,"price":44.39,"value":378025.24,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $43.96 to $44.935 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2113185,"source":{"system":"sec-edgar","filing":"0001714899-21-000114","document":"wf-form4_163856660331306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489921000114/wf-form4_163856660331306.xml","form_type":"4"}},{"id":2526426,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-03T21:32:25.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":16674,"price":49.87,"value":831532.38,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $49.27 to $50.17 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2121701,"source":{"system":"sec-edgar","filing":"0001714899-21-000097","document":"wf-form4_163597513221470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489921000097/wf-form4_163597513221470.xml","form_type":"4"}},{"id":2526425,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-03T21:32:25.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":1659,"price":48.61,"value":80643.99,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $48.20 to $49.19 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2138375,"source":{"system":"sec-edgar","filing":"0001714899-21-000097","document":"wf-form4_163597513221470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489921000097/wf-form4_163597513221470.xml","form_type":"4"}},{"id":2549097,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T20:27:34.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":4247,"price":50.99,"value":216554.53,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $50.90 to $51.14 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2140034,"source":{"system":"sec-edgar","filing":"0001714899-21-000093","document":"wf-form4_163346563868452.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489921000093/wf-form4_163346563868452.xml","form_type":"4"}},{"id":2549096,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T20:27:34.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":10782,"price":50.44,"value":543844.08,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $49.90 to $50.895 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2144281,"source":{"system":"sec-edgar","filing":"0001714899-21-000093","document":"wf-form4_163346563868452.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489921000093/wf-form4_163346563868452.xml","form_type":"4"}},{"id":2549095,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T20:27:34.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":3304,"price":49.38,"value":163151.52,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $48.85 to $49.81 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2155063,"source":{"system":"sec-edgar","filing":"0001714899-21-000093","document":"wf-form4_163346563868452.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489921000093/wf-form4_163346563868452.xml","form_type":"4"}},{"id":2579396,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-09-03T10:53:32.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":10892,"price":54.92,"value":598188.64,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $54.57 to $55.21 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2158367,"source":{"system":"sec-edgar","filing":"0001714899-21-000089","document":"wf-form4_163066639800542.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489921000089/wf-form4_163066639800542.xml","form_type":"4"}},{"id":2579395,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-09-03T10:53:32.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":7441,"price":54.27,"value":403823.07,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $53.57 to $54.56 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2169259,"source":{"system":"sec-edgar","filing":"0001714899-21-000089","document":"wf-form4_163066639800542.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489921000089/wf-form4_163066639800542.xml","form_type":"4"}},{"id":2593576,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-24T00:25:01.000Z","date":"2021-08-19","kind":"sale","acquired":false,"shares":750,"price":49.97,"value":37477.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $49.81 to $50.16 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2176700,"source":{"system":"sec-edgar","filing":"0001714899-21-000085","document":"wf-form4_162976467767655.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489921000085/wf-form4_162976467767655.xml","form_type":"4"}},{"id":2593575,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-24T00:25:01.000Z","date":"2021-08-19","kind":"sale","acquired":false,"shares":1626,"price":49.38,"value":80291.88,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $48.81 to $49.80 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 5000 restricted stock units held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2177450,"source":{"system":"sec-edgar","filing":"0001714899-21-000085","document":"wf-form4_162976467767655.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489921000085/wf-form4_162976467767655.xml","form_type":"4"}},{"id":2614941,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-04T23:14:09.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":9790,"price":51.94,"value":508492.6,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $51.42 to $52.405 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2174076,"source":{"system":"sec-edgar","filing":"0001714899-21-000080","document":"wf-form4_162811883181212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489921000080/wf-form4_162811883181212.xml","form_type":"4"}},{"id":2614940,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-04T23:14:09.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":8543,"price":50.8,"value":433984.4,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $50.42 to $51.41 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2183866,"source":{"system":"sec-edgar","filing":"0001714899-21-000080","document":"wf-form4_162811883181212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000171489921000080/wf-form4_162811883181212.xml","form_type":"4"}},{"id":2641367,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-06T20:14:11.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":2459,"price":77.837,"value":191401.183,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $77.67 to $78.25 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2192409,"source":{"system":"sec-edgar","filing":"0001209191-21-045422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121045422/doc4.xml","form_type":"4"}},{"id":2641366,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-06T20:14:11.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":12844,"price":77.349,"value":993470.556,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $76.67 to $77.665 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2194868,"source":{"system":"sec-edgar","filing":"0001209191-21-045422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121045422/doc4.xml","form_type":"4"}},{"id":2641365,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-06T20:14:11.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":3030,"price":76.379,"value":231428.37,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $75.67 to $76.66 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2207712,"source":{"system":"sec-edgar","filing":"0001209191-21-045422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121045422/doc4.xml","form_type":"4"}},{"id":2683451,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-04T00:08:23.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":354,"price":63.5,"value":22479.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2210742,"source":{"system":"sec-edgar","filing":"0001209191-21-037981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121037981/doc4.xml","form_type":"4"}},{"id":2683450,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-04T00:08:23.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":2102,"price":62.755,"value":131911.01,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $62.50 to $63.055 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2211096,"source":{"system":"sec-edgar","filing":"0001209191-21-037981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121037981/doc4.xml","form_type":"4"}},{"id":2683449,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-04T00:08:23.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":2750,"price":62.09,"value":170747.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $61.50 to $62.44 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2213198,"source":{"system":"sec-edgar","filing":"0001209191-21-037981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121037981/doc4.xml","form_type":"4"}},{"id":2683448,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-04T00:08:23.000Z","date":"2021-06-01","kind":"sale","acquired":false,"shares":13127,"price":60.982,"value":800510.714,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $60.48 to $61.46 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2215948,"source":{"system":"sec-edgar","filing":"0001209191-21-037981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121037981/doc4.xml","form_type":"4"}},{"id":2727429,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-05T20:13:27.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":851,"price":59.917,"value":50989.367,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $59.79 to $60.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2229075,"source":{"system":"sec-edgar","filing":"0001209191-21-030300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121030300/doc4.xml","form_type":"4"}},{"id":2727428,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-05T20:13:27.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":3485,"price":59.119,"value":206029.715,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $58.765 to $59.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2229926,"source":{"system":"sec-edgar","filing":"0001209191-21-030300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121030300/doc4.xml","form_type":"4"}},{"id":2727427,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-05T20:13:27.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":13997,"price":58.447,"value":818082.659,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $57.76 to $58.755 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2233411,"source":{"system":"sec-edgar","filing":"0001209191-21-030300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121030300/doc4.xml","form_type":"4"}},{"id":2758115,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-05T20:09:11.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":4586,"price":57.314,"value":262842.004,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $57.038 to $58.02 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2247408,"source":{"system":"sec-edgar","filing":"0001209191-21-025115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121025115/doc4.xml","form_type":"4"}},{"id":2758114,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-05T20:09:11.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":8516,"price":56.876,"value":484356.016,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $56.32 to $57.03 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2251994,"source":{"system":"sec-edgar","filing":"0001209191-21-025115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121025115/doc4.xml","form_type":"4"}},{"id":2758113,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-05T20:09:11.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":5232,"price":55.521,"value":290485.872,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $55.245 to $56.235 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2260510,"source":{"system":"sec-edgar","filing":"0001209191-21-025115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121025115/doc4.xml","form_type":"4"}},{"id":2758112,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-05T20:09:11.000Z","date":"2021-03-09","kind":"gift","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2265742,"source":{"system":"sec-edgar","filing":"0001209191-21-025115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121025115/doc4.xml","form_type":"4"}},{"id":2814129,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-03T21:19:51.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":68,"price":70.924,"value":4822.832,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $70.90 to $70.95 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2305742,"source":{"system":"sec-edgar","filing":"0001209191-21-016854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121016854/doc4.xml","form_type":"4"}},{"id":2814128,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-03T21:19:51.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":594,"price":69.648,"value":41370.912,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $69.28 to $69.96 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2305810,"source":{"system":"sec-edgar","filing":"0001209191-21-016854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121016854/doc4.xml","form_type":"4"}},{"id":2814127,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-03T21:19:51.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":1625,"price":68.459,"value":111245.875,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $68.155 to $69.11 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2306404,"source":{"system":"sec-edgar","filing":"0001209191-21-016854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121016854/doc4.xml","form_type":"4"}},{"id":2814126,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-03T21:19:51.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":3339,"price":67.69,"value":226016.91,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $67.15 to $68.135 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2308029,"source":{"system":"sec-edgar","filing":"0001209191-21-016854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121016854/doc4.xml","form_type":"4"}},{"id":2814125,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-03T21:19:51.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":3453,"price":66.545,"value":229779.885,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $66.15 to $67.105 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2311368,"source":{"system":"sec-edgar","filing":"0001209191-21-016854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121016854/doc4.xml","form_type":"4"}},{"id":2814124,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-03T21:19:51.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":5885,"price":65.626,"value":386209.01,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $65.15 to $66.13 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2314821,"source":{"system":"sec-edgar","filing":"0001209191-21-016854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121016854/doc4.xml","form_type":"4"}},{"id":2814123,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-03T21:19:51.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":3370,"price":64.423,"value":217105.51,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $64.12 to $65.10 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2320706,"source":{"system":"sec-edgar","filing":"0001209191-21-016854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121016854/doc4.xml","form_type":"4"}},{"id":2859324,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-17T00:40:42.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":960,"price":71.469,"value":68610.24,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $71.03 to $71.90 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 19,696 shares acquired pursuant to vesting of restricted stock units and issued directly to the Watts Family 2015 Trust dated July 7, 2015."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2324076,"source":{"system":"sec-edgar","filing":"0001209191-21-011004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121011004/doc4.xml","form_type":"4"}},{"id":2859323,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-17T00:40:42.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":8513,"price":70.172,"value":597374.236,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $69.71 to $70.66 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 19,696 shares acquired pursuant to vesting of restricted stock units and issued directly to the Watts Family 2015 Trust dated July 7, 2015."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2325036,"source":{"system":"sec-edgar","filing":"0001209191-21-011004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121011004/doc4.xml","form_type":"4"}},{"id":2869313,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-02-11T00:40:18.000Z","date":"2021-02-08","kind":"exercise","acquired":false,"shares":8800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"25% of the restricted stock units vested on February 8, 2020 (the \"Vesting Commencement Date\") and an additional 25% of the restricted stock units shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"25% of the restricted stock units vested on February 8, 2020 (the \"Vesting Commencement Date\") and an additional 25% of the restricted stock units shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date."}],"balance_after":17600,"derivative":{"underlying":"Common Stock","underlying_shares":8800},"source":{"system":"sec-edgar","filing":"0001209191-21-009455","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121009455/doc4.xml","form_type":"4"}},{"id":2869312,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-02-11T00:40:18.000Z","date":"2021-02-08","kind":"exercise","acquired":false,"shares":5516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"50% of the restricted stock units vested on February 8, 2020 and the remaining 50% of the restricted stock units vested on February 8, 2021, subject to the Reporting Person remaining a service provider of the Issuer through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"50% of the restricted stock units vested on February 8, 2020 and the remaining 50% of the restricted stock units vested on February 8, 2021, subject to the Reporting Person remaining a service provider of the Issuer through each such date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5516},"source":{"system":"sec-edgar","filing":"0001209191-21-009455","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121009455/doc4.xml","form_type":"4"}},{"id":2869311,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-11T00:40:18.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":811,"price":75.072,"value":60883.392,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $74.79 to $75.195 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2313853,"source":{"system":"sec-edgar","filing":"0001209191-21-009455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121009455/doc4.xml","form_type":"4"}},{"id":2869310,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":23347,"kind":"person","name":"Watts Ryan J.","position":1,"cik":"0001724310","reported_name":"Watts Ryan J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-11T00:40:18.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":1634,"price":74.051,"value":120999.334,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $73.62 to $74.50 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee."}],"balance_after":2314664,"source":{"system":"sec-edgar","filing":"0001209191-21-009455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724310/000120919121009455/doc4.xml","form_type":"4"}}],"next_cursor":"2021-02-11T00:40:18.000000Z,2869310"}